XM does not provide services to residents of the United States of America.
O
O

Oerlikon


News

Swiss stocks - Factors to watch on August 6

Swiss stocks - Factors to watch on August 6 ZURICH/GDANSK, Aug 6(Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: NOVARTIS NOVN.S Novartis and Viatris VTRS.O were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and development.
A
N
O

Oerlikon Says 2024 Operational EBITDA Margin Raised To 15.5-16.0%

BRIEF-Oerlikon Says 2024 Operational EBITDA Margin Raised To 15.5-16.0% Aug 6 (Reuters) - OC Oerlikon Corporation AG Pfaeffikon OERL.S : RAISING 2024 GUIDANCE AFTER STRONG EXECUTION IN THE FIRST HALF; SEPARATION ON TRACK Q2 SALES CHF 616 MILLION VERSUS COMPANY-COMPILED CONSENSUS OF CHF 598 MILLION Q2 ORDER INTAKE CHF 651 MILLION VERSUS COMPANY-COMP
O



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.